High Ground Medica Initiates Process to Secure LOI with Malta Enterprise as First Step Towards EU-GMP Certification; Announces Growth Financing
Summary
"I’m pleased to announce we have initiated this next step in our business plan which centers on cultivating high quality, potency consistent, stable cannabis using an aeroponic production process for wholesale distribution via our European distributors. Furthermore, as founding member of European cannabis medical association (https://eumca.org/), we firmly believe in quality of product, which is something that Jeff and his team at High Ground can supply our continent with,” said Nicholas Spiteri, CEO of Cannanalytica. Capturing as much of the value chain without incurring the cost of building out an expensive distribution network, (when dozens of distributors are short medical grade quality supply), should lead to strong profitability,” noted Jeff Callaway. "I’m pleased to announce we have initiated this next step in our business plan which centers on cultivating high quality, potency consistent, stable cannabis using an aeroponic production process for wholesale distribution via our European distributors. Capturing as much of the value chain without incurring the cost of building out an expensive distribution network, (when dozens of distributors are short medical grade quality supply), should lead to strong profitability,” noted Jeff Callaway.High Ground is also announcing the launch of a non-brokered private placement at $0.25/share.